Attached files

file filename
10-Q - GUIDED THERAPEUTICS, INC. - GUIDED THERAPEUTICS INCgthp10q63010.htm
EX-31 - CERTIFICATION - GUIDED THERAPEUTICS INCex31.htm
EX-3.1 - AMENDED CERTIFICATE OF INCORPORATION - GUIDED THERAPEUTICS INCex3one.htm
EX-4.12 - AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT - GUIDED THERAPEUTICS INCex4twelve.htm
EX-10.18 - AGREEMENT FOR COLLABORATION - GUIDED THERAPEUTICS INCex10eighteen.htm
 
 


 

 
EXHIBIT 32

SECTION 1350 CERTIFICATION

In connection with the Quarterly Report of Guided Therapeutics, Inc. (the "Company") on Form 10-Q for the quarter ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark L. Faupel, President, Chief Executive Officer and acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

 
(1)  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Date: August 12, 2010

 
/s/ MARK L. FAUPEL

 
Name: Mark L. Faupel

 
Title: President, Chief Executive Officer and acting Chief Financial Officer